Dr. Carter is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
55 Fruit Street
White 502
Boston, MA 02114Phone+1 617-726-8583
Summary
- Dr. Bob Carter is currently Professor and Chief of Neurosurgery at the Massachusetts General Hospital/Harvard Medical School, Boston, Massachusetts. He completed his B.A. with University Honors in Chemistry at Brigham Young University, his M.D. with AOA distinction at the Johns Hopkins School of Medicine, and his Ph.D. in genetic epidemiology at the Johns Hopkins School of Public Health. Dr. Carter trained in Neurosurgery at the Massachusetts General Hospital and remained on the faculty until he was recruited to UC San Diego in 2010 as Professor and Chair. While at UC San Diego, Dr. Carter led the formation of the UC San Diego Neurological Institute and co-directed the UCSD Brain Tumor Center. In 2017, Dr. Carter was recruited back to MGH to lead the Department of Neurosurgery, where he specializes in complex intracranial surgery for brain and skull base tumors including pituitary adenoma and meningioma and cerebrovascular pathology.
Dr. Carter lectures nationally and internationally on neurosurgery topics and serves on the editorial board of the Journal of Neurosurgery.
Clinical Expertise
- Neurosurgical oncology, Cerebrovascular disease, Neurosurgical trauma and critical care, Skull base surgery, Neurosurgery, Pituitary surgery, Cerebral aneurysm clipping, Meningiomas, Acoustic neuroma, Pituitary disease, Logistic models, Combined modality therapy, Radiosurgery, Gliomas, Subarachnoid hemorrhage, Glioblastoma, Astrocytoma, Cerebral angiography
Education & Training
- Massachusetts General HospitalResidency, Neurological Surgery, 1992 - 1998
- Johns Hopkins University School of MedicineClass of 1992
- Johns Hopkins University School of MedicinePhD, 1992
- Brigham Young UniversityBA, Chemistry, With University Honors, 1986
Certifications & Licensure
- NH State Medical License 2022 - 2026
- CA State Medical License 2009 - 2025
- MA State Medical License 1995 - 2025
- ME State Medical License 2020 - 2021
- American Board of Neurological Surgery Neurological Surgery
Awards, Honors, & Recognition
- Top Doctors:San Diego Area Castle Connolly, 2013
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
- Top Doctors:Southern California Castle Connolly, 2012
- Join now to see all
Clinical Trials
- Minimally Invasive Surgery Plus Rt-PA for ICH Evacuation Phase III Start of enrollment: 2013 Dec 30
- 5-Aminolevulinic Acid (5-ALA) to Enhance Visualization of Malignant Tumor Start of enrollment: 2016 May 01
- Gleolan for Visualization of Newly Diagnosed or Recurrent Meningioma Start of enrollment: 2020 Oct 28
Publications & Presentations
PubMed
- Clinical progress in the development of CAR T cells to treat malignant glioma.Eric P Grewal, Brian V Nahed, Bob S Carter, Elizabeth R Gerstner, William T Curry
Journal of Neuro-Oncology. 2025-02-01 - 1 citationsMutant IDH Modulates Suppressive Myeloid Populations in Malignant Glioma.Eric P Grewal, Leland G K Richardson, Jing Sun, Rishab Ramapriyan, Maria Martinez-Lage
Clinical Cancer Research. 2024-09-13 - Radical surgical resection with molecular margins is associated with improved survival in IDH wild-type glioblastoma.Elie Massaad, William J Smith, Joseph Bradley, Eric Esposito, Mihir Gupta
Neuro-Oncology. 2024-09-05
Journal Articles
- Original Article the Impact of Unmet Communication and Education Needs on Neurosurgical Patient and Caregiver Experiences of Care: A Qualitative Exploratory AnalysisGregory Seymann, Jeffrey Uppington, Bridget Wilson, Mitchel Berger, James Boggan, Bob Carter, Catherine Y Lau, Jennifer Varma, Alpesh Amin, Nasim Afsarmanesh, ScienceDirect
- Coding and Noncoding Landscape of Extracellular RNA Released by Human Glioma Stem CellsBob Carter, Fred Hochberg, Clark C Chen, Nature
- Detection of wtEGFR Amplification and EGFRvIII Mutation in CSF-Derived Extracellular Vesicles of Glioblastoma PatientsFigueroa JM, Skog J, Akers J, Li H, Komotar R, Jensen R, Ringel F, Yang I, Kalkanis S, Thompson R, LoGuidice L, Berghoff E, Parsa A, Liau L, Curry W, Cahill D, Bettego..., Neuro Oncol, 1/27/2017
- Join now to see all
Books/Book Chapters
Lectures
- "Lessons from the MGH in Neurosurgical Discovery: The Road Ahead"Boston, MA - 1/1/2017
- "Investigating Extracellular Vesicles in Glioma"Washington University, St. Louis, MO - 1/1/2017
- "Henderson Lecture: Lessons for the Surgeon Scientist: Extracellular Vesicles"University of Maryland, Baltimore, MD - 1/1/2017
- Join now to see all
Other
- The New Standard for Intraoperative Imaging EnvironmentsCarter BS
1/1/2012 - "Awake Craniotomy"Carter BS, KPBS
http://bit.ly/1QRckMH
1/1/2010 - "Brain Tumor Treatments"Carter BS, Interview, University of California, San Diego (UCSD) TV Dr. Bill Mobley
https://www.youtube.com/watch?v=ed0u847hfDA
1/1/2010 - Join now to see all
Press Mentions
- Bob Carter Named Senior Vice President for Health SciencesDecember 17th, 2024
- University of Utah Health Hires New ChiefDecember 17th, 2024
- Semaglutide so Effective at Treating Arthritis That Patients Were “More or Less Were Treated Out of the Study”November 2nd, 2024
- Join now to see all
Professional Memberships
- Member
- Fellow
Other Languages
- French
External Links
- Dr. Carter at MGHhttps://neurosurgery.mgh.harvard.edu/carter/
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: